| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. | Chief Medical Officer | Common Stock | 374K | $4.72M | $12.62 | May 9, 2024 | Direct |
| Zentalis Pharmaceuticals, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 338K | Feb 1, 2024 | Direct | ||
| Immuneering Corp | Director | Stock Option | 33.4K | Jun 12, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| IMRX | Immuneering Corp | Jun 12, 2024 | 1 | $0 | 4 | Jun 13, 2024 | Director |
| ZNTL | Zentalis Pharmaceuticals, Inc. | May 9, 2024 | 1 | -$42.4K | 4 | May 9, 2024 | Chief Medical Officer |
| ZNTL | Zentalis Pharmaceuticals, Inc. | Feb 1, 2024 | 2 | $0 | 4 | Feb 5, 2024 | Chief Medical Officer |
| IMRX | Immuneering Corp | Jun 14, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
| ZNTL | Zentalis Pharmaceuticals, Inc. | May 8, 2023 | 1 | $0 | 4 | May 10, 2023 | Director |
| ZNTL | Zentalis Pharmaceuticals, Inc. | May 8, 2023 | 0 | $0 | 3 | May 10, 2023 | Director |
| IMRX | Immuneering Corp | Jun 21, 2022 | 1 | $0 | 4 | Jun 23, 2022 | Director |
| IMRX | Immuneering Corp | Jan 14, 2022 | 1 | $328K | 4 | Jan 18, 2022 | Director |
| IMRX | Immuneering Corp | Jan 14, 2022 | 0 | $0 | 3 | Jan 18, 2022 | Director |